Occupe actuellement des postes chez aTyr Pharma Inc and Fate Therapeutics Inc
Position | Company | Period |
---|---|---|
Director | aTyr Pharma Inc | 1 novembre 2017 - |
Vice Chairman of the Board | Fate Therapeutics Inc | 1 janvier 2017 - |
Independent Director | Editas Medicine Inc | 1 janvier 2016 - 27 mars 2018 |
Chief Executive Officer, Director | aTyr Pharma Inc | 1 décembre 2015 - 1 novembre 2017 |
Vice Chairman of the Board | Fate Therapeutics Inc | None - |
Chief Executive Officer and Executive Chairman, Board of Directors | aTyr Pharma Inc | 1 septembre 2011 - 1 décembre 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-01-13 | 2023-01-13 |
Fate Therapeutics Inc
(FATE)
|
A Achat |
36 631
+14.9%
5,43198 906 USD |
36 631 +14.9% | 5,43 | 198 906 USD | |
2023-01-13 | 2023-01-11 |
Fate Therapeutics Inc
(FATE)
|
A Achat |
88 048
+55.7%
5,67499 232 USD |
88 048 +55.7% | 5,67 | 499 232 USD | |
2022-06-06 | 2022-06-03 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 364
-0.9%
22,7931 086 USD |
1 364 -0.9% | 22,79 | 31 086 USD | |
2022-03-11 | 2022-03-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
12 069
-7.0%
35,48428 208 USD |
12 069 -7.0% | 35,48 | 428 208 USD | |
2022-03-11 | 2022-03-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
19 493
-10.2%
34,73676 992 USD |
19 493 -10.2% | 34,73 | 676 992 USD |